Loading...
XTAE
SEMG
Market cap28mUSD
Jul 09, Last price  
259.10ILS
1D
0.19%
1Q
-3.03%
Name

Seach Medical Group Ltd

Chart & Performance

D1W1MN
XTAE:SEMG chart
P/E
56.28
P/S
0.55
EPS
0.05
Div Yield, %
4.63%
Shrs. gr., 5y
0.59%
Rev. gr., 5y
33.69%
Revenues
157m
-8.48%
2,004,0008,968,00012,302,00018,549,00028,834,00036,802,00067,340,000134,210,000150,324,000171,724,000157,154,000
Net income
2m
-88.73%
-5,356,0001,579,0002,957,0008,015,000-22,554,00011,967,0005,349,000-3,411,000-10,511,00013,524,0001,524,000
CFO
17m
+1.96%
-3,167,000627,0001,770,0003,707,000828,000-5,752,000-8,128,00017,394,000225,00016,286,99916,607,000
Dividend
Apr 02, 202512 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Seach Medical Group Ltd is an Israeli company, established in 2002 and headquartered in Ramat Gan, that specializes in the global production and distribution of therapeutic cannabis products. Its offerings include medicinal cannabis flower (inflorescence) and various oil-based compounds, primarily marketed under the 'Nitzan' brand. The company's product line also extends to 'power powder' and 'moodpicks'.
IPO date
May 21, 1990
Employees
145
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT